Published in AIDS Weekly, May 3rd, 2004
"Potent antiretroviral therapy stimulates robust and durable immune reconstitution among profoundly immunosuppressed patients that is clinically important," according to scientists in the United States.
In a study conducted by P.A. Sklar and coauthors at the National Institutes of Health, "[f]ifteen patients with cytomegalovirus retinitis (CMVR) were followed after discontinuing anti-cytomegalovirus therapy.
"No patient had progression or relapse for a median of 51 months," published data showed. "Survival from the diagnosis of CMVR was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.